CCL2 and atherosclerosis: Among the inflammatory chemokines involved in the process of atherosclerosis, MCP-1 (CCL2) is considered a potent culprit that is involved in the earliest events, progression and vascular injury in this disease because MCP-1 has strong chemotactic activity to recruit monocytes to inflamed blood vessel walls [6,7].